Age and stage defined | 18 (29.03%) |
02–05 (young children) | 1 (1.61%) |
10–19 (adolescents) | 2 (3.23%) |
10–24 (young people) | 2 (3.23%) |
10–25 (young people) | 1 (1.61%) |
10–25 (youth) | 1 (1.61%) |
11, 14 and 17 (adolescents) | 1 (1.61%) |
12–19 (adolescents) | 1 (1.61%) |
12–21 (adolescent and young adult) | 1 (1.61%) |
12–25 (young people) | 1 (1.61%) |
15–17 (adolescents) | 1 (1.61%) |
15–29 (adolescent and young adult) | 1 (1.61%) |
16–25 (young adults) | 1 (1.61%) |
18–30 (postadolescent young persons) | 1 (1.61%) |
19–25 (young adults) | 1 (1.61%) |
Adolescents (11–15) and young adults (16–25) | 1 (1.61%) |
Adolescents (11–18) and youth | 1 (1.61%) |
Age but not stage defined | 1 (1.61%) |
18–28 | 1 (1.61%) |
Stage but not age defined | 35 (56.45%) |
Adolescents | 7 (11.29%) |
Adolescents and young adults | 2 (3.23%) |
Adults | 1 (1.61%) |
Children | 2 (3.23%) |
Neonatal | 1 (1.61%) |
Young adults | 2 (3.23%) |
Young people | 15 (24.19%) |
Youth | 5 (8.06%) |
Neither age nor stage defined | 8 (12.90%) |
Young patients | 2 (3.23%) |
Not applicable | 6 (9.68%) |